financetom
Business
financetom
/
Business
/
Commerzbank on Overnight News
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Commerzbank on Overnight News
Oct 29, 2025 3:23 AM

05:46 AM EDT, 10/29/2025 (MT Newswires) -- Commerzbank in its "European Sunrise" note of Wednesday highlighted:

Markets: United States Treasuries flat in late New York session and Asia after soft seven-year auction. E-minis remain on the highs. The euro (EUR) falls to $1.163, yen (JPY) slides after Treasury Secretary Scott Bessent's comment. Brent trades around $64.5/barrel.

Trade: President Donald Trump thinks a deal with China and South Korea will be made. The U.S. Senate votes to terminate Trump's 50% tariff on Brazil. China buys first soybeans from the U.S. in months. Trump says fentanyl tariff could be cut from 20% to 10%.

Middle East: Israel orders strikes on Gaza after alleged cease-fire violations by Hamas.

==EUROPE:

France: National assembly votes for higher taxes on multinationals, potentially bringing in more than 20 billion euros next year, while the Senate is unlikely to sign off on the proposal (Le Monde).

Japan: Treasury Secretary Bessent says Japan's willingness to give Bank of Japan policy space is key.

U.K.: Ginance Minister Rachel Reeves says the United Kingdom can reap "huge benefits" from rebuilding relations with the European Union.

Slovenia plans five billion yuan Panda bonds next year.

==ASIA:

China pledges to "significantly" increase the share of consumption in the economy over the next five years, but wants to keep technology and manufacturing top priorities.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FDA approves Adaptimmune's gene therapy for rare cancer
US FDA approves Adaptimmune's gene therapy for rare cancer
Aug 2, 2024
Aug 2 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved Adaptimmune's first-of-its-kind gene therapy to treat adult patients with a type of advanced synovial sarcoma who have received prior chemotherapy. ...
Sector Update: Consumer Stocks Mixed Premarket Friday
Sector Update: Consumer Stocks Mixed Premarket Friday
Aug 2, 2024
09:13 AM EDT, 08/02/2024 (MT Newswires) -- Consumer stocks were mixed premarket Friday as the Consumer Staples Select Sector SPDR Fund ( XLP ) was up 0.4% and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) fell by 3.8% recently. Church & Dwight ( CHD ) shares declined by over 3% after saying it expects Q3 adjusted diluted...
Owens & Minor's Q2 Adjusted Net Income, Revenue Rise; 2024 Guidance Reaffirmed
Owens & Minor's Q2 Adjusted Net Income, Revenue Rise; 2024 Guidance Reaffirmed
Aug 2, 2024
09:19 AM EDT, 08/02/2024 (MT Newswires) -- Owens & Minor ( OMI ) reported Q2 adjusted net income Friday of $0.36 per share, up from $0.18 a year earlier. Analysts polled by Capital IQ expected $0.33. Net revenue for the quarter ended June 30 was $2.67 billion, up from $2.56 billion a year earlier. Analysts surveyed by Capital IQ expected...
Newmark Group Q2 Adjusted Earnings, Revenue Rise; Reaffirms 2024 Outlook
Newmark Group Q2 Adjusted Earnings, Revenue Rise; Reaffirms 2024 Outlook
Aug 2, 2024
09:20 AM EDT, 08/02/2024 (MT Newswires) -- Newmark Group ( NMRK ) reported Q2 pretax adjusted earnings Friday of $0.25 per share, up from $0.21 a year earlier. Three analysts polled by Capital IQ expected $0.20. Revenue for the quarter ended June 30 was $633.4 million, up from $585.8 million a year earlier. Three analysts surveyed by Capital IQ expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved